Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tenet HealthcareMEX:THC 79 Debt-to-EBITDA is 2.11 as of Mar. 2026, which is 62% below its 10-year median of 5.50. GuruFocus rates MEX:THC with a GF Score™ of 79/100 and a GF Value™ of MXN3,040.11. The stock has 2 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Tenet Healthcare ranks worse than 56.28% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Tenet Healthcare's Debt-to-EBITDA or its related term are showing as below:
MEX:THC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.91 Med: 5.5 Max: 8.31
Current: 2.71
During the past 13 years, the highest Debt-to-EBITDA Ratio of Tenet Healthcare was 8.31. The lowest was 1.91. And the median was 5.50.
MEX:THC's Debt-to-EBITDA is ranked worse than 56.28% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs MEX:THC: 2.71
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Tenet Healthcare Debt-to-EBITDA Related Terms
Tenet Healthcare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Tenet Healthcare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:THC vs DVA, EHC, ENSG: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Tenet Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenet Healthcare Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tenet Healthcare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Tenet Healthcare (MEX:THC) has a Debt-to-EBITDA of 2.11 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Tenet Healthcare. This is 62% below median its historical median of 5.50. Over the past decade, Tenet Healthcare's Debt-to-EBITDA has ranged from 1.91 to 8.31. According to the industry distribution chart, Tenet Healthcare ranks #269 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 56.3%.
Is Tenet Healthcare's Debt-to-EBITDA too high?
Tenet Healthcare's current Debt-to-EBITDA of 2.11 is 62% below median its 10-year median of 5.50. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 8.31. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Tenet Healthcare's value of 2.11 is 6.2% below this industry median. Based on the distribution chart, Tenet Healthcare ranks #269 out of 478 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tenet Healthcare has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's Debt-to-EBITDA compare to DVA and EHC?
According to the Healthcare Providers & Services industry distribution chart, Tenet Healthcare ranks #269 out of 478 companies for Debt-to-EBITDA. This places Tenet Healthcare in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Tenet Healthcare's value of 2.11 is 6.2% below this benchmark. Historically, Tenet Healthcare's own Debt-to-EBITDA has ranged from 1.91 to 8.31 over the past decade. While the company's 10-year median is 5.50 vs. the industry median of 2.25, Tenet Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tenet Healthcare's current Debt-to-EBITDA of 2.11 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Tenet Healthcare. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenet Healthcare's current Debt-to-EBITDA is 2.11, which is 62% below median its own 10-year median of 5.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Tenet Healthcare (MEX:THC) has a current Debt-to-EBITDA of 2.11. The stock's GF Value™ is MXN3,040.11, compared to a current price of MXN3,547.50 — trading 16.7% above its estimated fair value. The current Debt-to-EBITDA is 2.11, which is 62% below median its 10-year median of 5.50 and 6.2% below the Healthcare Providers & Services industry median of 2.25. Tenet Healthcare's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Tenet Healthcare (MEX:THC), the current Debt-to-EBITDA is 2.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenet Healthcare (MEX:THC) Overvalued in 2026?
Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued.
The current stock price of MXN3,547.50 is trading 16.7% above its estimated GF Value™ of MXN3,040.11.
Key valuation signals for MEX:THC:
Debt-to-EBITDA: 2.11 (62% below median its 10-year median of 5.50)
GF Value™: MXN3,040.11 vs. price of MXN3,547.50 (16.7% above fair value)
Industry Position: 6.2% below the Healthcare Providers & Services median (#269 of 478)
No single metric tells the full story. See the MEX:THC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
79GF Score
Get the complete analysis for MEX:THC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:THC has been successfully added to your 
